Progression-free survival as surrogate end point for overall survival in clinical trials of HER2-targeted agents in HER2-positive metastatic breast cancer
| Image |  |
|---|---|
| Description | scientific article published on 8 March 2016 |
| Author/s | |
| Publication date | March 8, 2016 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |